PortfoliosLab logoPortfoliosLab logo
GN0M.DE vs. DR7E.DE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GN0M.DE vs. DR7E.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and Global X Autonomous & Electric Vehicles UCITS ETF USD Accumulating (DR7E.DE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GN0M.DE achieves a 12.99% return, which is significantly lower than DR7E.DE's 41.08% return.


GN0M.DE

1D
5.61%
1M
11.50%
YTD
12.99%
6M
9.82%
1Y
55.73%
3Y*
-1.90%
5Y*
10Y*

DR7E.DE

1D
-1.47%
1M
7.64%
YTD
41.08%
6M
38.98%
1Y
84.37%
3Y*
18.20%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

GN0M.DE vs. DR7E.DE - Yearly Performance Comparison


2026 (YTD)20252024202320222021
GN0M.DE
Global X Genomics & Biotechnology UCITS ETF
12.99%5.67%-12.40%-9.04%-32.50%-7.09%
DR7E.DE
Global X Autonomous & Electric Vehicles UCITS ETF USD Accumulating
41.08%15.37%0.76%23.30%-30.28%-2.43%

Correlation

The correlation between GN0M.DE and DR7E.DE is 0.55, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.55

Correlation (3Y)
Calculated over the trailing 3-year period

0.58

Correlation (All Time)
Calculated using the full available price history since Nov 19, 2021

0.61

The correlation between GN0M.DE and DR7E.DE has been stable across timeframes, ranging from 0.55 to 0.61 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GN0M.DE vs. DR7E.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GN0M.DE
GN0M.DE Risk / Return Rank: 5858
Overall Rank
GN0M.DE Sharpe Ratio Rank: 6060
Sharpe Ratio Rank
GN0M.DE Sortino Ratio Rank: 6161
Sortino Ratio Rank
GN0M.DE Omega Ratio Rank: 5454
Omega Ratio Rank
GN0M.DE Calmar Ratio Rank: 6868
Calmar Ratio Rank
GN0M.DE Martin Ratio Rank: 5050
Martin Ratio Rank

DR7E.DE
DR7E.DE Risk / Return Rank: 9393
Overall Rank
DR7E.DE Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
DR7E.DE Sortino Ratio Rank: 9393
Sortino Ratio Rank
DR7E.DE Omega Ratio Rank: 9090
Omega Ratio Rank
DR7E.DE Calmar Ratio Rank: 9696
Calmar Ratio Rank
DR7E.DE Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GN0M.DE vs. DR7E.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) and Global X Autonomous & Electric Vehicles UCITS ETF USD Accumulating (DR7E.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GN0M.DEDR7E.DEDifference
Sharpe ratioReturn per unit of total volatility

-1.66

Sortino ratioReturn per unit of downside risk

-1.76

Omega ratioGain probability vs. loss probability

1.33

1.57

-0.24

Calmar ratioReturn relative to maximum drawdown

3.32

8.52

-5.20

Martin ratioReturn relative to average drawdown

8.35

24.61

-16.26

GN0M.DE vs. DR7E.DE - Sharpe Ratio Comparison

The current GN0M.DE Sharpe Ratio is 2.00, which is lower than the DR7E.DE Sharpe Ratio of 3.67. The chart below compares the historical Sharpe Ratios of GN0M.DE and DR7E.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


GN0M.DEDR7E.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.00

3.67

-1.66

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.34

0.29

-0.63

Drawdowns

GN0M.DE vs. DR7E.DE - Drawdown Comparison

The maximum GN0M.DE drawdown since its inception was -67.19%, which is greater than DR7E.DE's maximum drawdown of -40.66%. Use the drawdown chart below to compare losses from any high point for GN0M.DE and DR7E.DE.


Loading charts...

Drawdown Indicators


GN0M.DEDR7E.DEDifference

Max Drawdown

Largest peak-to-trough decline

-67.19%

-40.66%

-26.53%

Max Drawdown (1Y)

Largest decline over 1 year

-16.68%

-9.95%

-6.73%

Max Drawdown (3Y)

Largest decline over 3 years

-48.19%

-33.99%

-14.20%

Current Drawdown

Current decline from peak

-41.03%

-2.08%

-38.95%

Average Drawdown

Average peak-to-trough decline

-43.13%

-18.33%

-24.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.65%

3.45%

+3.20%

Volatility

GN0M.DE vs. DR7E.DE - Volatility Comparison

The current volatility for Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) is 8.15%, while Global X Autonomous & Electric Vehicles UCITS ETF USD Accumulating (DR7E.DE) has a volatility of 9.64%. This indicates that GN0M.DE experiences smaller price fluctuations and is considered to be less risky than DR7E.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GN0M.DEDR7E.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.15%

9.64%

-1.49%

Volatility (6M)

Calculated over the trailing 6-month period

19.69%

16.91%

+2.78%

Volatility (1Y)

Calculated over the trailing 1-year period

27.68%

23.14%

+4.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.49%

25.01%

+6.48%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.49%

25.01%

+6.48%

GN0M.DE vs. DR7E.DE - Expense Ratio Comparison

Both GN0M.DE and DR7E.DE have an expense ratio of 0.50%.


Dividends

GN0M.DE vs. DR7E.DE - Dividend Comparison

Neither GN0M.DE nor DR7E.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


GN0M.DE and DR7E.DE have a correlation of 0.55, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Both ETFs have the same 0.50% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

GN0M.DE and DR7E.DE have the same expense ratio: 0.50% per year.

GN0M.DE is categorized as Health & Biotech Equities, while DR7E.DE is Technology Equities. GN0M.DE tracks Solactive Genomics, while DR7E.DE tracks Solactive Autonomous & Electric Vehicles.

Portfolio Optimizer

Find the right allocation for GN0M.DE and DR7E.DE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer